Small Caps

In this exclusive interview, Jess Fertig hosts James McDonnell, CEO of Prescient Therapeutics (ASX: PTX), a biotech innovator in the healthcare sector. Discover how PTX's lead asset, PTX 100, is advancing through crucial Phase 2 trials targeting cutaneous T cell lymphoma (CTCL), with promising response rates and minima

In this exclusive interview, Jess Fertig welcomes Andrew Vigar, Chairman of Terra Uranium (ASX: T92.ASX), to discuss the company's exciting strategic moves into critical minerals like tungsten, tin, molybdenum, and bismuth. Discover how Terra Uranium is leveraging innovative technologies such as optical sorting to unlo

In this exclusive interview, Rita Brooks, Exec Chair of Tambourah Metals (ASX: TMB), shares exciting updates on the company's exploration strategies in Western Australia’s renowned gold and critical minerals regions. Discover how Tambourah's drilling program is uncovering high-grade gold, antimony, and silver prospects

In this exclusive interview, Alexander Scanlon, MD & CEO of Barton Gold Holdings (ASX: BGD), sits down with Jess Fertig to reveal the company’s strategic outlook and exciting milestones. Discover how Barton Gold is leveraging its existing infrastructure and regional assets to unlock $2.7 billion in free cash flow, with

EVE Health (ASX: EVE) chief executive officer Damian Wood joins Small Caps to discuss the formation of a strategic clinic partnership with TeleDocs Clinic. The collaboration agreement will deliver online prescribing access and nationwide opportunities to market an erectile dysfunction oral soluble film and a dysmenorrh

NoviqTech (ASX: NVQ) chief executive officer Freddy El Turk joins Small Caps to discuss the AI intelligence and distributed ledger technology specialist's recent corporate moves. Most recently NoviqTech and Australia's Livium (ASX: LIT) agreed to collaborate to support the tokenisation of environmental benefits from ad